loadpatents
Patent applications and USPTO patent grants for Miyashiro; Julie M..The latest application filed is for "5-substituted indazoles as kinase inhibitors".
Patent | Date |
---|---|
Pyridine CDK9 kinase inhibitors Grant 9,650,358 - Mastracchio , et al. May 16, 2 | 2017-05-16 |
5-substituted indazoles as kinase inhibitors Grant 9,163,007 - Akritopoulou-Zanze , et al. October 20, 2 | 2015-10-20 |
CDK9 kinase inhibitors Grant 8,969,375 - Lai , et al. March 3, 2 | 2015-03-03 |
5-substituted Indazoles As Kinase Inhibitors App 20140343066 - Akritopoulou-Zanze; Irini ;   et al. | 2014-11-20 |
Cdk9 Kinase Inhibitors App 20140275153 - Lai; Chunqiu ;   et al. | 2014-09-18 |
Pyridine Cdk9 Kinase Inhibitors App 20140275011 - Mastracchio; Anthony ;   et al. | 2014-09-18 |
Chemical entities to be used for Wee1 inhibition for the treatment of cancer Grant 8,716,297 - Woods , et al. May 6, 2 | 2014-05-06 |
5-substituted indazoles as kinase inhibitors Grant 8,648,069 - Akritopoulou-Zanze , et al. February 11, 2 | 2014-02-11 |
4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL]benzenesulfonami- de for the treatment of inflammation or an inflammation-associated disorder Grant RE44,048 - Talley , et al. March 5, 2 | 2013-03-05 |
New Chemical Entities To Be Used For Wee1 Inhibition For The Treatment Of Cancer App 20130018045 - Woods; Keith W. ;   et al. | 2013-01-17 |
Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases Grant 7,956,185 - Diebold , et al. June 7, 2 | 2011-06-07 |
Pyrroloquinoxalinone inhibitors of poly(ADP-ribose)polymerase Grant 7,790,721 - Giranda , et al. September 7, 2 | 2010-09-07 |
5-substituted Indazoles As Kinase Inhibitors App 20090203690 - Akritopoulou-Zanze; Irini ;   et al. | 2009-08-13 |
Inhibitors Of Poly(adp-ribose)polymerase App 20080161292 - Giranda; Vincent L. ;   et al. | 2008-07-03 |
Inhibitors Of Polo-like Kinases App 20080015192 - Diebold; Robert B. ;   et al. | 2008-01-17 |
Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation Grant 6,951,949 - Talley , et al. October 4, 2 | 2005-10-04 |
Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation App 20050131050 - Talley, John J. ;   et al. | 2005-06-16 |
Anilino liver X-receptor modulators Grant 6,900,244 - Van Camp , et al. May 31, 2 | 2005-05-31 |
Sulfone liver X-receptor modulators Grant 6,822,120 - Becker , et al. November 23, 2 | 2004-11-23 |
Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation App 20040192930 - Talley, John J. ;   et al. | 2004-09-30 |
Heterocyclic glycyl beta-alanine derivatives App 20040127477 - Chandrakumar, Nizal Samuel ;   et al. | 2004-07-01 |
Anilino liver X-receptor modulators App 20040087632 - Van Camp, Jennifer Ann ;   et al. | 2004-05-06 |
Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation Grant 6,716,991 - Talley , et al. April 6, 2 | 2004-04-06 |
Sulfone liver X-receptor modulators App 20040048920 - Becker, Daniel P. ;   et al. | 2004-03-11 |
Heterocyclic glycyl .beta.-alanine derivatives Grant 6,689,754 - Chandrakumar , et al. February 10, 2 | 2004-02-10 |
Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation Grant 5,760,068 - Talley , et al. June 2, 1 | 1998-06-02 |
Substituted pyrazolyl benzenesulfonamides for the treatment of gastrointestinal conditions Grant 5,753,688 - Talley , et al. May 19, 1 | 1998-05-19 |
LTA.sub.4 Hydrolase inhibitors Grant 5,585,492 - December 17, 1 | 1996-12-17 |
Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation Grant 5,563,165 - Talley , et al. October 8, 1 | 1996-10-08 |
Substituted pyrazolyl benzenesulfonamide compounds for the treatment of inflammation Grant 5,508,426 - Talley , et al. April 16, 1 | 1996-04-16 |
Substituted pyrazolyl benzenesulfonamides Grant 5,466,823 - Talley , et al. November 14, 1 | 1995-11-14 |
Leukotriene B.sub.4 synthesis inhibitors Grant 5,356,919 - Djuric , et al. October 18, 1 | 1994-10-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.